206 related articles for article (PubMed ID: 23986307)
1. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
[TBL] [Abstract][Full Text] [Related]
2. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
[TBL] [Abstract][Full Text] [Related]
3. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
Kulkarni AS; Bhatia MS
PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
[TBL] [Abstract][Full Text] [Related]
4. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Plantago major L. seed mucilage as a rate controlling matrix for sustained release of propranolol hydrochloride.
Saeedi M; Morteza-Semnani K; Sagheb-Doust M
Acta Pharm; 2013 Mar; 63(1):99-114. PubMed ID: 23482316
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
Prabakaran D; Singh P; Kanaujia P; Vyas SP
Int J Pharm; 2003 Jun; 259(1-2):173-9. PubMed ID: 12787645
[TBL] [Abstract][Full Text] [Related]
7. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
8. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
Chen S; Zhu J; Cheng J
Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
[TBL] [Abstract][Full Text] [Related]
10. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
11. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
Bresolin JR; Largura MC; Dalri CC; Hoffer G; Rodrigues CA; Lucinda-Silva RM
Drug Dev Ind Pharm; 2014 Apr; 40(4):503-10. PubMed ID: 23594298
[TBL] [Abstract][Full Text] [Related]
12. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
Bendas ER
Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589
[TBL] [Abstract][Full Text] [Related]
13. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
[TBL] [Abstract][Full Text] [Related]
14. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
Miranda A; Millán M; Caraballo I
Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
17. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
18. Role of cellulose ether polymers on ibuprofen release from matrix tablets.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613
[TBL] [Abstract][Full Text] [Related]
19. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
20. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
